The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Repurposing Market Research Report 2024
Synopsis
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
The global Drug Repurposing market was valued at US$ 24570 million in 2023 and is anticipated to reach US$ 30920 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Repurposing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repurposing.
Report Scope
The Drug Repurposing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Repurposing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repurposing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
Segment by Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Repurposing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
The global Drug Repurposing market was valued at US$ 24570 million in 2023 and is anticipated to reach US$ 30920 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Repurposing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repurposing.
Report Scope
The Drug Repurposing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Repurposing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repurposing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
Segment by Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Repurposing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncology
1.2.3 CNS Diseases
1.2.4 Neurodegenerative Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2019-2030)
2.2 Drug Repurposing Growth Trends by Region
2.2.1 Global Drug Repurposing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Repurposing Historic Market Size by Region (2019-2024)
2.2.3 Drug Repurposing Forecasted Market Size by Region (2025-2030)
2.3 Drug Repurposing Market Dynamics
2.3.1 Drug Repurposing Industry Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2019-2024)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2019-2024)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2023
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repurposing Breakdown Data by Type
4.1 Global Drug Repurposing Historic Market Size by Type (2019-2024)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2025-2030)
5 Drug Repurposing Breakdown Data by Application
5.1 Global Drug Repurposing Historic Market Size by Application (2019-2024)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Repurposing Market Size (2019-2030)
6.2 North America Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Repurposing Market Size by Country (2019-2024)
6.4 North America Drug Repurposing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Repurposing Market Size (2019-2030)
7.2 Europe Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Repurposing Market Size by Country (2019-2024)
7.4 Europe Drug Repurposing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size (2019-2030)
8.2 Asia-Pacific Drug Repurposing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Repurposing Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Repurposing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Repurposing Market Size (2019-2030)
9.2 Latin America Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Repurposing Market Size by Country (2019-2024)
9.4 Latin America Drug Repurposing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size (2019-2030)
10.2 Middle East & Africa Drug Repurposing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Repurposing Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Repurposing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Drug Repurposing Introduction
11.1.4 Astellas Pharma Revenue in Drug Repurposing Business (2019-2024)
11.1.5 Astellas Pharma Recent Development
11.2 Biovista
11.2.1 Biovista Company Detail
11.2.2 Biovista Business Overview
11.2.3 Biovista Drug Repurposing Introduction
11.2.4 Biovista Revenue in Drug Repurposing Business (2019-2024)
11.2.5 Biovista Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Drug Repurposing Introduction
11.3.4 Novartis Revenue in Drug Repurposing Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Drug Repurposing Introduction
11.4.4 AbbVie Revenue in Drug Repurposing Business (2019-2024)
11.4.5 AbbVie Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repurposing Introduction
11.5.4 Pfizer Revenue in Drug Repurposing Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Drug Repurposing Introduction
11.6.4 Allergan Revenue in Drug Repurposing Business (2019-2024)
11.6.5 Allergan Recent Development
11.7 NuMedii
11.7.1 NuMedii Company Detail
11.7.2 NuMedii Business Overview
11.7.3 NuMedii Drug Repurposing Introduction
11.7.4 NuMedii Revenue in Drug Repurposing Business (2019-2024)
11.7.5 NuMedii Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oncology
Table 3. Key Players of CNS Diseases
Table 4. Key Players of Neurodegenerative Diseases
Table 5. Key Players of Others
Table 6. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drug Repurposing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug Repurposing Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Drug Repurposing Market Share by Region (2019-2024)
Table 10. Global Drug Repurposing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Drug Repurposing Market Share by Region (2025-2030)
Table 12. Drug Repurposing Market Trends
Table 13. Drug Repurposing Market Drivers
Table 14. Drug Repurposing Market Challenges
Table 15. Drug Repurposing Market Restraints
Table 16. Global Drug Repurposing Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Drug Repurposing Market Share by Players (2019-2024)
Table 18. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2023)
Table 19. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drug Repurposing Product Solution and Service
Table 23. Date of Enter into Drug Repurposing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Repurposing Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Drug Repurposing Revenue Market Share by Type (2019-2024)
Table 27. Global Drug Repurposing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Drug Repurposing Revenue Market Share by Type (2025-2030)
Table 29. Global Drug Repurposing Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Drug Repurposing Revenue Market Share by Application (2019-2024)
Table 31. Global Drug Repurposing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Drug Repurposing Revenue Market Share by Application (2025-2030)
Table 33. North America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Drug Repurposing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Drug Repurposing Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Drug Repurposing Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Drug Repurposing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Drug Repurposing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Astellas Pharma Company Detail
Table 49. Astellas Pharma Business Overview
Table 50. Astellas Pharma Drug Repurposing Product
Table 51. Astellas Pharma Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 52. Astellas Pharma Recent Development
Table 53. Biovista Company Detail
Table 54. Biovista Business Overview
Table 55. Biovista Drug Repurposing Product
Table 56. Biovista Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 57. Biovista Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Drug Repurposing Product
Table 61. Novartis Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. AbbVie Company Detail
Table 64. AbbVie Business Overview
Table 65. AbbVie Drug Repurposing Product
Table 66. AbbVie Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Drug Repurposing Product
Table 71. Pfizer Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Allergan Company Detail
Table 74. Allergan Business Overview
Table 75. Allergan Drug Repurposing Product
Table 76. Allergan Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 77. Allergan Recent Development
Table 78. NuMedii Company Detail
Table 79. NuMedii Business Overview
Table 80. NuMedii Drug Repurposing Product
Table 81. NuMedii Revenue in Drug Repurposing Business (2019-2024) & (US$ Million)
Table 82. NuMedii Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Repurposing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug Repurposing Market Share by Type: 2023 VS 2030
Figure 3. Oncology Features
Figure 4. CNS Diseases Features
Figure 5. Neurodegenerative Diseases Features
Figure 6. Others Features
Figure 7. Global Drug Repurposing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Drug Repurposing Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Repurposing Report Years Considered
Figure 13. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Drug Repurposing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Drug Repurposing Market Share by Region: 2023 VS 2030
Figure 16. Global Drug Repurposing Market Share by Players in 2023
Figure 17. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2023
Figure 19. North America Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Drug Repurposing Market Share by Country (2019-2030)
Figure 21. United States Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Drug Repurposing Market Share by Country (2019-2030)
Figure 25. Germany Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Drug Repurposing Market Share by Region (2019-2030)
Figure 33. China Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Drug Repurposing Market Share by Country (2019-2030)
Figure 41. Mexico Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Drug Repurposing Market Share by Country (2019-2030)
Figure 45. Turkey Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Drug Repurposing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Astellas Pharma Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 48. Biovista Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 50. AbbVie Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 52. Allergan Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 53. NuMedii Revenue Growth Rate in Drug Repurposing Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
